Health Equity Considerations as a Differentiator in Value Narratives Provide Opportunity for Life Sciences’ Global HTA Submissions

Trinity Life Sciences Introduces a Dedicated Value Center of Excellence, Delivering A Uniquely Integrated Combination of Market Access and HEOR Expertise

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces a dedicated Value Center of Excellence (COE) that provides end-to-end partnership along the value journey to Market Access and Health Economics and Outcomes Research (HEOR) teams, from strategy to communication. The COE approaches U.S. and global value work through a uniquely integrated combination of market access and HEOR expertise. Trinity’s Value COE is pioneering the integration of health equity into value strategy.

For a new asset launch in life sciences, a compelling value narrative that communicates differentiation to multiple stakeholders can mean favorable access and an optimal price point. The challenge in reaching this goal is multifaceted—a holistic, compliant value story and fast coverage recommendations are important, but so is pulling through the value communication strategy to value communication tools. It takes seamless internal collaboration within a life sciences organization to create consistency and efficiency throughout the value journey: from evidence planning to value prop development through to value dossier creation, medical education and beyond.

“HTA agencies are beginning to include health equity considerations into their access recommendations,” explained Monica Martin de Bustamante, Senior Partner and Head of Advisory at Trinity Life Sciences. “An emerging role for Trinity’s Value COE is incorporating the work of the health equity team into access materials in a way that moves the needle for payers—reducing silos and increasing the impact of the organization’s work.”

“Value work in life sciences should be driven by both HEOR and Access mindsets—HEOR expertise ensures that the work is scientifically rigorous and rooted in evidence, and the Access point of view brings deep understanding of global payer decision motivation and nuance,” added Mary Fletcher-Louis, a Managing Director in Trinity Life Sciences’ Evidence, Value, Access & Pricing practice and Head of Trinity’s Value COE. “Trinity’s Value COE combines HEOR and Access approaches to create powerful, successful value propositions with context.”

Trinity’s Value Center of Excellence

Trinity’s Value Center of Excellence (COE) offers end-to-end strategic partnership through a uniquely integrated combination of market access and HEOR expertise. The COE provides cross-functional support ranging across the continuum of value needs, from early value concepts to value proposition, U.S./global value dossier and objection handlers. Through strong partnership with clients, Trinity’s Value COE creates all the tools needed to shape value strategy and communicate value.

Webinar: Health Equity in Health Technology Assessment (HTA) Outcomes

A webinar on April 30, Health Equity in HTA Outcomes: Navigating the New Frontier, will feature Trinity value, access and pricing experts Mary Fletcher-Louis, Max Hunt and Pinar Bilir delving into the emerging role of health equity considerations as a differentiator in value narratives for global HTA submissions.

Life sciences executives are welcome to register for the webinar here.

About Trinity Life Sciences

With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits. To learn more about how Trinity is elevating the industry and driving evidence to action, visit TrinityLifeSciences.com.